Publicaciones en colaboración con investigadores/as de Princess Margaret Cancer Centre (5)

2023

  1. Oncology phase I trial design and conduct: time for a change - MDICT Guidelines 2022

    Annals of Oncology, Vol. 34, Núm. 1, pp. 48-60

2021

  1. OX40 agonist BMS-986178 alone or in combination with nivolumab and/or ipilimumab in patients with advanced solid tumors

    Clinical Cancer Research, Vol. 27, Núm. 2, pp. 460-472

2020

  1. Efficacy and Safety of Nivolumab plus Ipilimumab in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Sorafenib: The CheckMate 040 Randomized Clinical Trial

    JAMA Oncology

2019

  1. An integrative approach to inform optimal administration of OX40 agonist antibodies in patients with advanced solid tumors

    Clinical Cancer Research, Vol. 25, Núm. 22, pp. 6709-6720

2011

  1. Defining the critical hurdles in cancer immunotherapy

    Journal of Translational Medicine